QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Sustained Virological Response 12 Weeks after Therapy (SVR12) with Direct-Acting Antivirals (DAA) in Select Asian Populations with Chronic Hepatitis C Genotype 1 (HCV GT 1): A Meta-Analysis of Real-World Effectiveness from Asia 会议论文 作者:  Ji, Fanpu;  Wei, Bin;  Yeo, Yee Hui;  Zou, Biyao;  Ogawa, Eiichi 收藏  |  浏览/下载：11/0  |  提交时间：2019/11/26 Real-world Effectiveness (RWE) and Adverse Events with Sofosbuvir plus Ribavirin (SOF plus RBV) Based Therapies in Chronic Hepatitis C Genotype 3 (CHC GT 3) Patients in Asia-A Systematic Review of 8 Studies and 3510 Patient 会议论文 作者:  Wei, Bin;  Ji, Fanpu;  Yeo, Yee Hui;  Ogawa, Eiichi;  Henry, Linda 收藏  |  浏览/下载：2/0  |  提交时间：2019/11/26 Real-world Effectiveness (RWE) of Sofosbuvir plus Ribavirin (SOF plus RBV) Chronic Hepatitis C Genotype 2 (CHC GT 2) in Asia: A Systemic Review and Meta-analysis of Pooled SVR12 会议论文 作者:  Wei, Bin;  Ji, Fanpu;  Yeo, Yee Hui;  Zou, Biyao;  Ogawa, Eiichi 收藏  |  浏览/下载：7/0  |  提交时间：2019/11/26 Real Life Effectiveness of Direct-Acting Antivirals (DAAs) in Asian Patients with Chronic Hepatitis C Genotype 1: Systematic Review and Meta-analysis of 33 Published Articles and 7942 patients 会议论文 作者:  Ji, Fanpu;  Wei, Bin;  Yeo, Yee Hui;  Zou, Biyao;  Ogawa, Eiichi 收藏  |  浏览/下载：6/0  |  提交时间：2019/11/26